[1] TRAYES KP,COKENAKES SEH.Breast cancer treatment[J].Am Fam Physician,2021,104(2):171-178.
[2] 徐茜茜,李静蔚,孙雪,等.基于PI3K/Akt通路的中药治疗乳腺癌研究进展[J].现代中西医结合杂志,2022,31(05):713-717.
XU QQ,LI JW,SUN X,et al.Research progress of PI3K/Akt pathway-based herbal medicine for breast cancer treatment[J].Modern Journal of Integrated Traditional Chinese and Western Medicine,2022,31(05):713-717.
[3] 李云祥,梁引库,高飞雄,等.中药治疗乳腺癌疾病研究进展[J].中国实验方剂学杂志,2019,25(3):211-219.
LI YX,LIANG YK,GAO FX,et al.Research progress of traditional Chinese medicine in treating breast cancer[J].Chinese Journal of Experimental Traditional Medical Formulae,2019,25(3):211-219.
[4] 黄亚萍,肖惠玲,李艳红,等.贝母素乙抑制MEK/ERK的磷酸化对新生小鼠柯萨奇B病毒性心肌炎心肌细胞凋亡和炎症水平的影响[J].中药药理与临床,2020,36(1):94-99.
HUANG YP,XIAO HL,LI YH,et al.Effects of peiminine inhibiting MEK/ERK phosphorylation on cardiomyocyte apoptosis and inflammation level in neonatal mice with coxsackie virus B myocarditis[J].Pharmacology and Clinics of Chinese Materia Medica,2020,36(1):94-99.
[5] 张玉人,林洪生,张英.贝母素甲、贝母素乙对4T1乳腺癌细胞炎性微环境的干预调节作用[J].中国中医基础医学杂志,2014,20(11):1504-1506.
ZHANG YR,LIN HS,ZHANG Y,et al.Intervention effect of peimine,peiminine on the inflammatory microenvironment of 4T1 breast cancer cell[J].Chinese Journal of Basic Medicine in Traditional Chinese Medicine,2014,20(11):1504-1506.
[6] 饶军,熊爱华,张康梅.Peiminine通过调控COX-2/PGE2/EGFR信号通路促进人结肠癌HCT-116细胞凋亡的分子机制[J].实用癌症杂志,2021,36(06):871-874.
RAO J,XIONG AH,ZHANG KM.Molecular mechanism of peiminine promotes apoptosis of human colon cancer HCT-116 cells by regulating COX-2/PGE2/EGFR signaling pathway[J].The Practical Journal of Cancer,2021,36(06):871-874.
[7] 唐倩倩,王云飞,聂勇战,等.贝母素乙对5种肿瘤细胞的化疗增敏作用研究[J].中国药房,2017,28(34):4796-4800.
TANG QQ,WANG YF,NIE YZ,et al.Study on the effect of peiminine on increasing the chemosensitivity of 5 kinds of cancer cells[J].China Pharmacy,2017,28(34):4796-4800.
[8] 丁志丹,方泽民,王旭广,等.贝母素乙调控PI3K/Akt/mTOR通路减缓上皮-间质转化进程抑制人肺癌A549细胞侵袭及迁移的研究[J].中草药,2019,50(6):1382-1387.
DING ZD,FANG ZM,WANG XG,et al.Inhibition of peiminine on invasion and migration of human lung cancer A549 cells by decreasing epithelial-mesenchymal transition process via PI3K/Akt/mTOR pathway[J].Chinese Traditional and Herbal Drugs,2019,50(6):1382-1387.
[9] ZHAO B,SHEN C,ZHENG Z,et al.Peiminine inhibits glioblastoma in vitro and in vivo through cell cycle arrest and autophagic flux blocking[J].Cell Physiol Biochem,2018,51(4):1566-1583.
[10] BOCK FJ,TAIT SWG.Mitochondria as multifaceted regulators of cell death[J].Nat Rev Mol Cell Biol,2020,21(2):85-100.
[11] KOPINSKI PK,SINGH LN,ZHANG S,et al.Mitochondrial DNA variation and cancer[J].Nat Rev Cancer,2021,21(7):431-445.
[12] LI L,QI R,ZHANG L,et al.Potential biomarkers and targets of mitochondrial dynamics[J].Clin Transl Med,2021,11(8):e529.
[13] 滕菲,魏敏,刘畅,等.KLF5基因表达下调促进宫颈癌细胞线粒体中细胞色素C释放并诱导凋亡的实验研究[J].中国妇产科临床杂志,2020,21(1):28-30.
TENG F,WEI M,LIU C,et al.Down-regulation of KLF5 gene expression promotes cytochrome C release and induces apoptosis in mitochondria of cervical cancer cells[J].Chin J Clin Obstetrics GynEcol,2020,21(1):28-30.
[14] LI F,XIE W,FANG Y,et al.HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1[J].J Cancer,2021,12(1):281-291.
[15] 万春梅,胡雪莲,陈欢,等.罗格列酮通过PTEN/PI3K/Akt通路影响人肝癌细胞QGY-7701的增殖及凋亡[J].基因组学与应用生物学,2020,39(5):2418-2423.
WAN CM,HU XL,CHEN H,et al.Rosiglitazone affects proliferation and apoptosis of human liver cancer cell line QGY-7701 through PTEN/PI3K/Akt pathway[J].Genomics and Applied Biology,2020,39(5):2418-2423.
[16] 林洪,王文浩.Bad蛋白磷酸化和剪切修饰对神经胶质瘤细胞凋亡的调控作用[J].中国现代医学杂志,2019,29(19):58-61.
LIN H,WANG WH.Phosphorylation and cleavage-modification of Bad on the regulation of cellular apoptosis in glioma cells[J].China Journal of Modern Medicine,2019,29(19):58-61.